IP Library Granted Patent US 10,416,110
Granted Patent B2
US 10,416,110 · App. 15/696,402 · Granted Sep 17, 2019

Voltammetric systems for assaying biological analytes

Inventor: Huan-Ping Wu (Granger, IN)
Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
G01N27/3272C12Q1/005G01N27/327G01N27/3273G01N27/48G01N27/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,416,110
App. No.
15/696,402
Granted
Sep 17, 2019
Kind
B2
Abstract

The present invention relates to systems, methods, and devices for determining the concentration of an analyte in a sample. The use of linear, cyclic, or acyclic voltammetric scans and/or semi-integral, derivative, or semi-derivative data treatment may provide for increased accuracy when determining the concentration of an analyte in a sample. Hematocrit compensation in combination with the data treatments may reduce the hematocrit effect with regard to a glucose analysis in whole blood. In another aspect, fast scan rates may reduce the hematocrit effect.

Claims (32)

1. A system for determining a concentration of an analyte in a sample, comprising:

a measuring device including at least two device contacts in electrical communication with a display through electrical circuitry, the measuring device being configured to apply an acyclic scan to the sample; and

a sensor strip receivable by the measuring device, the sensor strip including:

a first sensor strip contact;

a second sensor strip contact;

a working electrode in electrical communication with the first sensor strip contact;

a counter electrode in electrical communication with the second sensor strip contact; and

a first reagent layer on (i) the working electrode, (ii) the counter electrode, or (iii) both the working electrode and the counter electrode, the first reagent layer including an oxidoreductase and at least one species of a redox pair.

2. The system of claim 1 , wherein the analyte is glucose.

3. The system of claim 1 , wherein the first reagent layer is on both the working electrode and the counter electrode.

4. The system of claim 1 , wherein the sensor strip further includes a second reagent layer on at least the counter electrode, the second reagent layer including at least one species of a redox pair.

5. The system of claim 1 , wherein the electrical circuitry includes a charger configured to apply the acyclic scan to the sensor strip, and wherein the sensor strip contains the sample.

6. The system of claim 1 , wherein the acyclic scanning comprises forward and reverse linear scans, the forward scan starting at a different voltage than where the reverse scan stops.

7. The system of claim 1 , wherein the acyclic scan includes forward and reverse linear scans, the forward scan starting and the reverse scan ending at a point at most ±20 mV away from a formal potential E°′ of a redox pair.

8. The system of claim 1 , wherein the acyclic scan includes forward and reverse linear scans within the steady-state region of a redox pair, the forward and reverse scans having a scan range from 10 to 200 mV.

9. A system for determining a concentration of an analyte in a sample, comprising:

a measuring device including

at least two device contacts in electrical communication with a display through electrical circuitry, the measuring device being configured to apply a voltammetric scan to the sample; and

a sensor strip receivable by the measuring device, the sensor strip including:

a first sensor strip contact;

a second sensor strip contact;

a working electrode in electrical communication with the first sensor strip contact;

a counter electrode in electrical communication with the second sensor strip contact; and

a first reagent layer on (i) the working electrode, the (ii) the counter electrode, or (iii) both the working electrode and the counter electrode, the first reagent layer including an oxidoreductase and at least one species of a redox pair.

10. The system of claim 9 , wherein the analyte is glucose.

11. The system of claim 9 , wherein the voltammetric scan includes a linear scan.

12. The system of claim 9 , wherein the voltammetric scan includes a cyclic scan.

13. The system of claim 9 , wherein the first reagent layer is on both the working electrode and the counter electrode.

14. The system of claim 9 , wherein the first reagent layer is on the working electrode, and wherein the sensor strip further includes a second reagent layer on the counter electrode, the second reagent layer including at least one species of a redox pair.

15. The system of claim 9 , wherein the electrical circuitry includes a charger configured to apply the voltammetric scan to the sensor strip, and wherein the sensor strip contains the sample.

16. The system of claim 9 , wherein the charger is configured to apply a linear scan to the sensor strip.

17. The system of claim 9 , wherein the charger is configured to apply a cyclic scan to the sensor strip.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: WU, HUAN-PING
To: BAYER HEALTHCARE LLC
Reel/Frame 043496/0714 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2017
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 043496/0814 →
Continuity (5)
Continuation 14495556 · Sep 24, 2014
Division 13611557 · Sep 12, 2012
Division 11596309
Provisional Application 60571388 · May 14, 2004
Related Publication 20170370871A1 · Dec 28, 2017
Cited By (1)
US 12,295,701